KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Non-Current Assets (2018 - 2025)

Adaptive Biotechnologies' Non-Current Assets history spans 8 years, with the latest figure at $212.6 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 16.85% year-over-year to $212.6 million; the TTM value through Dec 2025 reached $910.9 million, down 7.56%, while the annual FY2025 figure was $212.6 million, 16.85% down from the prior year.
  • Non-Current Assets for Q4 2025 was $212.6 million at Adaptive Biotechnologies, up from $209.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $525.6 million in Q3 2021 and bottomed at $209.2 million in Q3 2025.
  • The 5-year median for Non-Current Assets is $285.1 million (2023), against an average of $308.6 million.
  • The largest annual shift saw Non-Current Assets soared 140.96% in 2021 before it plummeted 43.44% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $520.6 million in 2021, then tumbled by 43.44% to $294.5 million in 2022, then dropped by 14.78% to $250.9 million in 2023, then grew by 1.86% to $255.6 million in 2024, then dropped by 16.85% to $212.6 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Non-Current Assets are $212.6 million (Q4 2025), $209.2 million (Q3 2025), and $234.8 million (Q2 2025).